Cannabidiol (CBD) (INN) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract. CBD is considered to have a wide scope of potential medical applications - due to clinical reports showing the lack of side effects, particularly a lack of psychoactivity (as is typically associated with ∆9-THC).
- government licensed operation
- all products are made from legal EU hemp varieties
- a guarantee of natural phytocannabinoid content
Safety and Side Effects of Cannabidiol – A review of clinical data and relevant animal studies by Kerstin If and and Dr. med. Franjo Grotenhermen, nova-Institut (www.nova-institut.eu) The study was commissioned by the European Industrial Hemp Association (www.eiha.org)